Effects of probiotic bacterium Weissella cibaria CMU on periodontal health and microbiota: a randomised, double-blind, placebo-controlled trial

BACKGROUND: Weissella cibaria CMU (oraCMU) has been commercially available in the market for several years as oral care probiotics. The present study aimed to evaluate the effects of oraCMU-containing tablets on periodontal health and oral microbiota. METHODS: A randomised, double-blind, placebo-con...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Mi-Sun, Lee, Dong-Suk, Lee, Seung-Ah, Kim, Myoung-Suk, Nam, Seoul-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469353/
https://www.ncbi.nlm.nih.gov/pubmed/32878603
http://dx.doi.org/10.1186/s12903-020-01231-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469353/
https://www.ncbi.nlm.nih.gov/pubmed/32878603
http://dx.doi.org/10.1186/s12903-020-01231-2

Ejemplares similares